Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised, placebo-controlled, double-blind efficacy study of emollient V0034CR in atopic dermatitis
2005-002803-18Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing V0034CR (DEXERYL) emollient + Locapred with Placebo emollient + Locapred (2 arms). Started Aug 2005; status: completed.
02
Drugs
glycerol
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2005-002803-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002803-18.